MDGL FY 2017 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MDGLMadrigal Pharmaceuticals, Inc.

$10B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$77,000

Operating Income

-$32M

Net Income

-$31M

EPS (Diluted)

$-2.54

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$192M

Total Liabilities

$10M

Stockholders' Equity

$182M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$77,000	-$156	-49259.0%
Operating Income	-$32M	-$25M	-27.6%
Net Income	-$31M	-$26M	-18.1%